Most recently, a novel automated immunoassay for AFP-L3 has been developed [34], [35], which enabled us to overcome this difficulty and showed that AFP-L3% was closely related to poor prognosis even in AFP negative HCC. Here, AFP is linked to hepatocellular carcinoma.